drugset / Trial / NCT02134249

Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

NCT02134249

Phase 2/3 Completed 200 enrolled Benha University
RandomizedSingle-groupSingle-blindPrevention

Summary

The purpose of this study is to compare the effect of oral Diosmin to oral Cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent intracytoplasmic sperm injection (ICSI).

Timeline

Start
2014-04
Primary completion
2015-09
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cabergoline Small molecule 0.5 mg Oral
Comparator Diosmin Small molecule 500 mg Oral

Indications